MYRIAD GENETICS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $824.5 | $837.6 | $753.2 | $678.4 | $690.6 |
| Operating income | -$387.2 | -$123.5 | -$257.4 | -$140.6 | -$190.5 |
| Net income | -$365.9 | -$127.3 | -$263.3 | -$112.0 | -$27.2 |
| Balance Sheet | |||||
| Total debt | $125.0 | $40.5 | — | — | — |
| Cash Flow Statement | |||||
| Free cash flow | — | — | — | -$151.6 | $0.6 |
| Share repurchases | — | — | — | — | $0.0 |
Shares outstanding 95.6M · Free float 98.1%
Annual filing data through FY ended December 31, 2025; float as of September 22, 2026.